Rural China's hypertension battle: can village doctors turn the tide?
NCT ID NCT03527719
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large trial tests whether a program led by village doctors can help control high blood pressure in rural China. Over 33,000 participants will receive training, discounted medications, and a simple treatment protocol. The study aims to see if this approach improves blood pressure control and reduces heart disease and dementia over several years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
village doctor-led multifaceted intervention (training, protocol, incentives, discounted meds)
What this could lead to
If successful, this could provide a scalable model for improving blood pressure control in underserved rural areas, potentially reducing heart disease and dementia.
What could go wrong
This is a large but early-stage implementation trial; results may not generalize to other regions or healthcare systems. Long-term adherence and sustainability are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of China Medical University
Shenyang, Liaoning, 110001, China